Studying Pain Processing in Fibromyalgia and Rheumatoid Arthritis
Observes how pain is processed in adults with fibromyalgia or rheumatoid arthritis.
Key facts
- Who runs it
- University of Florida
- Where
- Gainesville, United StatesSee the site
- Trial code
- Registry title
- Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 22 Mar 2022
- Expected to end
- 28 Jul 2027
- Type of study
- Observational, 3 groups
- Record updated
- 19 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-70 with fibromyalgia or rheumatoid arthritis, and for healthy volunteers without significant pain, fatigue, depression or anxiety.
- Age
- 18 to 70 years
- Sex
- All sexes can join.
- Disease stage
- Fibromyalgia meeting the 1990 and 2011 American College of Rheumatology criteria, or rheumatoid arthritis meeting the 2010 ACR-EULAR classification criteria.
Main reasons for not taking part
- Diabetes
- Cancer
- Advanced liver, kidney or cardiovascular disease
- Neuropathic pain
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Ages 18-70
- Fulfills the 1990 and 2011 American College of Rheumatology Criteria for FM
- Fulfills the 2010 ACR-EULAR classification criteria for RA
- Healthy volunteers: No significant pain/fatigue/depression/anxiety
Who cannot take part
- Diabetes
- Cancer
- Advanced liver, kidney or cardiovascular disease
- Neuropathic pain
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in United States
- University of FloridaGainesville, United StatesContact: Melyssa GodfreyTaking people
About the trial
What the trial wants to find out
Fibromyalgia (FM) is a chronic musculoskeletal pain disorder that afflicts up to 4% of the general population. The evaluation of pain mechanisms in FM has shown predominant central abnormalities and therefore has been designated as nociplastic pain syndrome. Rheumatoid arthritis (RA) is characterized by polyarthritis and pain from inflamed tissues, consistent with nociceptive pain. FM and RA patients may utilize overlapping pain mechanisms resulting in nociceptive and nociplastic pain.
The 3 groups in the trial
- Fibromyalgia
Participants who fulfill the 1990 and 2011 American College of Rheumatology Criteria for FM.
- Rheumatoid Arthritis
Participants who fulfill the 2010 American College of Rheumatology (ACR)-European League against rheumatism (EULAR) classification criteria for RA.
- Healthy Volunteers
Participants who do not have significant pain/fatigue/anxiety/depression.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes
- Plain-language title
- Studying Pain Processing in Fibromyalgia and Rheumatoid ArthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05277025, who can take part
- Record updated
- 19 August 2026